India’s drug regulator has not adopted AI for regulatory approvals: Govt
In response to the AI use in drug approval query, J.P. Nadda said CDSCO continues to rely on scientific and technical review for regulatory decisions and the Subject Expert Committee examines clinical trial approvals. The post India’s drug regulator has not adopted AI for regulatory approvals: Govt appeared first on MEDIANAMA .
Record details
Published: 6 August 2026
Source: MediaNama (IN)
Category: News
Topics: Regulation · Healthcare · Biotech
Retrieved: 7 August 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Parliament asks for deepfake complaint data, the govt responds with laws instead
MediaNama (IN) · 7 August 2026
SEBI is using AI to monitor social media for fraud. India has been here before
MediaNama (IN) · 10 August 2026
Biotech giant Amgen says patient data stolen from third-party cloud systems
The Record (Recorded Future News) · 3 August 2026
Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push
Above the Law (legal tech) · 11 August 2026
Delhi HC Justice Prathiba Singh questions mandatory AI disclosure for lawyers
MediaNama (IN) · 13 August 2026
xAI sues Minnesota over law banning AI ‘nudification’ tools
MediaNama (IN) · 30 July 2026
How to cite this record
ethics.ai (6 August 2026), “India’s drug regulator has not adopted AI for regulatory approvals: Govt,” evidence record 17377, https://ethics.ai/record/17377 (originally published by MediaNama (IN)).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.